Therefore, PDE inhibitors could be postulated to improve AD symptoms by restoring synaptic function due to restoration of cyclic AMP response element-binding protein (CREB) signaling pathway (García-Osta et al., 2012). This evidence concerns the gene CREB1 and Alzheimer disease.